Modified Le Fort I interpositional grafting of the atrophied maxilla – a retrospective study of 106 cases over 10 years

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00026086

Enrollment

106

Registered

2021-09-20

Start date

2019-02-10

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K08.2

Interventions

Group 1: OPG/FRS prä modified Le Fort I interpositional grafting OPG/FRS post OP OPG/FRS post implant placement OPG/z.T. FRS at subsequent follow-up appointments

Eligibility

Sex/Gender

All

Age

18 Years to 88 Years

Inclusion criteria

Inclusion criteria: Patients who have undergone a modified Le Fort I interpositional grafting. Atrophied maxilla - Cawood class iV and V.

Exclusion criteria

Exclusion criteria: Exclusion criteria were pregnancy, poor general health conditions (patients undergoing chemotherapy or radiotherapy for head and neck malignancies, severely immunocompromised patients and diabetic patients with poor glycemic control) and patients treated with amino-bisphosphonates.

Design outcomes

Primary

Measure	Time frame
Analysis of the panoramic radiographs and lateral cephalometric images to assess the gain and stability of the maxillary bone height and the peri-implant bone loss.	—

Secondary

Measure	Time frame
Survival time analysis according to Kaplan Meier for the assessment of implant survival Buser's criteria for assessing implant success	—

Countries

Germany

Contacts

Public ContactHendrik Terheyden

Klinik für Mund-, Kiefer- und Plastische Gesichtschirurgie DRK-Kliniken Nordhessen

mkganmeldung@drk-nh.de056130865530

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026